Search Results - "Neale, M. H."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window by Boyd, S R, Tan, D, Bunce, C, Gittos, A, Neale, M H, Hungerford, J L, Charnock-Jones, S, Cree, I A

    Published in British journal of ophthalmology (01-04-2002)
    “…Background: Improved local treatment of uveal melanoma makes it possible for many patients to retain the affected eye, but a proportion will develop secondary…”
    Get full text
    Journal Article
  2. 2

    FLASH Is an Essential Component of Cajal Bodies by Barcaroli, D., Dinsdale, D., Neale, M. H., Bongiorno-Borbone, L., Ranalli, M., Munarriz, E., Sayan, A. E., McWilliam, J. M., Smith, T. M., Fava, E., Knight, R. A., Melino, G., De Laurenzi, V.

    “…Cajal bodies are small nuclear organelles with a number of nuclear functions. Here we show that FLICE-associated huge protein (FLASH), originally described as…”
    Get full text
    Journal Article
  3. 3

    Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth by Boyd, S R, Tan, D S W, de Souza, L, Neale, M H, Myatt, N E, Alexander, R A, Robb, M, Hungerford, J L, Cree, I A

    Published in British journal of ophthalmology (01-04-2002)
    “…Background: Tumour microvascularity is a significant determinant of prognosis for a large number of different tumours, including uveal melanoma. The…”
    Get full text
    Journal Article
  4. 4

    Combination chemotherapy for choroidal melanoma : ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside by NEALE, M. H, MYATT, N, CREE, I. A, KURBACHER, C. M, FOSS, A. J. E, HUNGERFORD, J. L, PLOWMAN, P. N

    Published in British journal of cancer (01-03-1999)
    “…Treatment of choroidal melanoma by chemotherapy is usually unsuccessful, with response rates of less than 1% reported for dacarbazine (DTIC)-containing…”
    Get full text
    Journal Article
  5. 5

    Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma by Neale, M H, Myatt, N E, Khoury, G G, Weaver, P, Lamont, A, Hungerford, J L, Kurbacher, C M, Hall, P, Corrie, P G, Cree, I A

    Published in Melanoma research (01-12-2001)
    “…Cutaneous and uveal melanoma both have a poor prognosis and chemotherapy is usually unsuccessful. We have previously reported the activity of a number of…”
    Get full text
    Journal Article
  6. 6

    Abnormalities of the transforming growth factor-beta pathway in ocular melanoma by Myatt, Nyree, Aristodemou, Petros, Neale, Michael H., Foss, Alex J. E., Hungerford, John L., Bhattacharya, Shomi, A Cree, Ian

    Published in The Journal of pathology (01-12-2000)
    “…The majority of ocular melanomas occur in the uveal tract. Chemotherapy is generally ineffective and large tumours requiring enucleation have a greater than…”
    Get full text
    Journal Article
  7. 7

    Heterogeneity of chemosensitivity of metastatic cutaneous melanoma by Cree, I A, Neale, M H, Myatt, N E, de Takats, P G, Hall, P, Grant, J, Kurbacher, C M, Reinhold, U, Neuber, K, MacKie, R M, Chana, J, Weaver, P C, Khoury, G G, Sartori, C, Andreotti, P E

    Published in Anti-cancer drugs (01-06-1999)
    “…Advanced melanoma has a poor prognosis and chemotherapy provides little benefit for most patients. This may be related to heterogeneity of chemosensitivity as…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Relationship between expression of topoisomerase II isoforms and chemosensitivity in choroidal melanoma by Satherley, Kirsten, de Souza, Lavinia, H. Neale, Michael, A. Alexander, Robert, Myatt, Nyree, J. E. Foss, Alex, L. Hungerford, John, D. Hickson, Ian, A. Cree, Ian

    Published in The Journal of pathology (01-10-2000)
    “…Choroidal melanoma has a high mortality rate and responds poorly to existing chemotherapy, but unexpected ex vivo sensitivity of a subset of these tumours to…”
    Get full text
    Journal Article
  10. 10

    The ex vivo effect of high concentrations of doxorubicin on recurrent ovarian carcinoma by Neale, Michael H, Lamont, Alan, Hindley, Andrew, Kurbacher, Christian M, Cree, Ian A

    Published in Anti-cancer drugs (01-11-2000)
    “…The cardiotoxicity of anthracyclines has largely prevented dose intensification, but the use of liposomal preparations (e.g. Caelyx/Doxil) allows much higher…”
    Get full text
    Journal Article
  11. 11

    Ex vivo activity of XR5000 against solid tumors by Neale, Michael H, Charlton, Peter A, Cree, Ian A

    Published in Anti-cancer drugs (01-07-2000)
    “…Topoisomerases I and II unravel DNA during transcription, DNA replication and DNA repair. Inhibitors of both enzymes are important anticancer drugs, but only…”
    Get full text
    Journal Article
  12. 12

    Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma by Sharma, Sanjay, Neale, Michael H, Di Nicolantonio, Federica, Knight, Louise A, Whitehouse, Pauline A, Mercer, Stuart J, Higgins, Bernard R, Lamont, Alan, Osborne, Richard, Hindley, Andrew C, Kurbacher, Christian M, Cree, Ian A

    Published in BMC cancer (03-07-2003)
    “…We wished to evaluate the clinical response following ATP-Tumor Chemosensitivity Assay (ATP-TCA) directed salvage chemotherapy in a series of UK patients with…”
    Get full text
    Journal Article
  13. 13
  14. 14